logo
AAFA urges long-term AGOA renewal to boost US-Africa trade

AAFA urges long-term AGOA renewal to boost US-Africa trade

Fibre2Fashion22-07-2025
Beth Hughes, vice president of trade and customs policy at the American Apparel and Footwear Association (AAFA), has delivered testimony before the Office of the United States Trade Representative (USTR), highlighting the importance of renewing the African Growth and Opportunity Act (AGOA) for calendar year 2026.
Speaking at the annual review hearing (Docket Number USTR-2025-0012), Hughes stated that AGOA plays a pivotal role in driving US private-sector investment and employment across Africa and the United States. She shared testimonials from AAFA member companies, underscoring the impact of AGOA on business expansion and job creation.
Hughes said that one member company recently inaugurated a new garment factory in Togo, employing over 250 local workers trained over the past eight months. The company plans to expand the workforce to 500, with finished goods shipped to a US-based warehouse that employs more than 100 Americans.
Beth Hughes of AAFA has urged the USTR to renew AGOA for 2026, citing its critical role in boosting US investment and job creation in Africa and the US. She shared member success stories in Togo, Madagascar, Ghana, and Tanzania, and proposed enhancements like triennial reviews and improved customs systems. Hughes called AGOA a 'success story' and pushed for long-term renewal.
She further noted that another US apparel company is preparing to construct a facility in Madagascar to relocate nearly 50 per cent of its production from China, Vietnam, and Indonesia. However, Hughes warned that this investment is entirely dependent on AGOA's renewal, as losing duty-free access would render the project unviable.
In Ghana, a US company taking advantage of AGOA has become the country's largest private employer, with over 6,000 workers and plans to double that number by year-end. Much of the company's production has shifted from Asia to Ghana due to the cost competitiveness enabled by AGOA.
Hughes also mentioned a long-standing AAFA member, founded in 1987, that has fully transitioned production from China to Madagascar and Tanzania since 2007. The company now employs over 10,000 workers—mostly women—and supplies 50 million garments annually to over 60,000 US small businesses, supporting around 3 million American jobs.
She emphasised that AGOA's third-country fabric rule is vital, as it allows apparel manufacturers in lesser developed AGOA countries to source inputs from outside the continent while textile infrastructure in Africa is still being developed. At present, African suppliers provide only about 10 per cent of the cotton yarn and fabric used by local apparel manufacturers.
To enhance AGOA's effectiveness and utilisation, Hughes said AAFA supports several targeted improvements. These include converting the annual eligibility review to a triennial cycle, allowing cumulation from African Union countries that have ratified the African Continental Free Trade Area (AfCFTA), and replacing outdated textile visa requirements with modern customs cooperation. She also recommended adjusting apparel quotas and revising the graduation criteria for AGOA beneficiaries.
Calling AGOA a 'success story,' Hughes urged Congress and the Administration to renew the programme before the September 30 deadline and for the longest possible duration to provide certainty and encourage long-term investment.
'The time to act is now,' she said. 'AGOA has helped build a strong foundation for economic partnership, industrial growth, and mutual prosperity between the US and Africa. Let's not allow that progress to stall.'
Fibre2Fashion News Desk (SG)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US tariff hike to hit Indian exports, may push RBI towards rate cuts
US tariff hike to hit Indian exports, may push RBI towards rate cuts

Time of India

time12 minutes ago

  • Time of India

US tariff hike to hit Indian exports, may push RBI towards rate cuts

As the US mulls imposing higher tariffs on a range of imported goods, India — one of its top trading partners — is staring at a potential economic setback. With nearly 18% of India's exports heading to the US, any tariff escalation could dent growth, disrupt key sectors like textiles, pharma, and auto components, and nudge the Reserve Bank of India (RBI) toward more aggressive rate cuts. Economists estimate that US-bound exports contribute 2.2%

Donald Trump's tariffs unlikely to derail Apple's iPhone manufacturing in India: Here's why
Donald Trump's tariffs unlikely to derail Apple's iPhone manufacturing in India: Here's why

Mint

time12 minutes ago

  • Mint

Donald Trump's tariffs unlikely to derail Apple's iPhone manufacturing in India: Here's why

The United States' decision to impose 25 per cent tariffs on Indian goods is expected to have minimal impact on Apple's growing reliance on India as a key iPhone manufacturing base, according to analysts and industry insiders. Despite concerns over increased costs for American consumers, experts believe the move is unlikely to disrupt Apple's long-term production plans in the region. Notably, the tariff measure, announced by President Donald Trump and taking effect on Friday, has sparked concern among Indian businesses. However, industry observers suggest the decision may be more strategic posturing than a sign of long-term trade hostility. In recent months, Apple has shifted much of its India-based iPhone production to cater almost entirely to the US market. Between March and May, Foxconn, one of Apple's primary manufacturing partners, exported iPhones worth $3.2 billion from India, with nearly all units destined for the United States. 'It's too early to determine whether this development will reshape Apple's manufacturing roadmap in India,' said an executive familiar with the company's plans. 'These decisions are made with a longer horizon in mind.' Data from Counterpoint Research shows India supplied 71 per cent of all iPhones sold in the US between April and June, compared to just 31 per cent during the same period last year, a shift largely driven by a dip in exports from China. The trend reflects Apple's broader strategy of reducing dependency on Chinese factories amid mounting geopolitical tensions. Analysts argue that, even with the added tariffs, producing iPhones in India remains a financially viable option, thanks to factors such as lower labour costs, improved local sourcing of components, and government incentives. 'India continues to be one of Apple's two primary manufacturing hubs alongside China,' said Tarun Pathak, Research Director at Counterpoint. 'Making supply chain changes this close to new model releases is highly complex. Business will likely continue as usual.' Trump has frequently criticised Apple for assembling its products overseas, voicing frustrations over the company's moves to expand production in countries like India instead of returning jobs to the US. In a remark from May, Trump reportedly told Apple CEO Tim Cook: 'We put up with all the plants you built in China for years... we are not interested in you building in India, India can take care of themselves.' Despite such statements, analysts believe Apple is unlikely to reverse course. Faisal Kawoosa, chief analyst at Techarc, noted that Apple may absorb increased costs rather than hinder its India expansion. 'iPhones in the US are mostly sold through operator deals,' he said. 'Rather than raising retail prices, the added cost might simply be spread over consumers' monthly instalment plans.' (With inputs from Reuters)

Rajasthan Aushdhalaya Pvt. Ltd. Reaches ₹2000 Crore NPA Score
Rajasthan Aushdhalaya Pvt. Ltd. Reaches ₹2000 Crore NPA Score

Business Standard

time12 minutes ago

  • Business Standard

Rajasthan Aushdhalaya Pvt. Ltd. Reaches ₹2000 Crore NPA Score

VMPL New Delhi [India], July 31: India's Most Rapidly Advancing Ayurvedic Nutraceutical Powerhouse Rajasthan Aushdhalaya Pvt. Ltd. (RAPL Group), a pioneer in the Ayurvedic nutraceutical sector, has achieved a significant milestone by surpassing a net worth of ₹2000 crore. This achievement is not merely a financial benchmark--it reflects the growing confidence in Ayurveda as a credible health system that harmoniously blends ancient wisdom with modern therapeutic technologies. Global Recognition and Validation In a recent development, the Dubai-based investment firm Refasa formally recognized Rajasthan Aushdhalaya Pvt. Ltd. as one of India's most ideal and high-performing companies. Refasa's independent audit confirmed RAPL's net worth at ₹2000 crore, positioning it among the top Ayurvedic and nutraceutical companies in the country. RAPL's high NPA Score stands out, especially when compared to similar companies, further underscoring its credibility and sustained growth. With over 20 million patients treated across India, this recognition affirms RAPL's financial transparency, operational excellence, and consumer trust. The company proudly collaborates with over 65,000 doctors operating from their own clinics across India--from Kashmir to Kanyakumari, and Gujarat to Arunachal Pradesh--making it the only Ayurvedic company with such an extensive clinical outreach. From Vision to National Mission Founded with a mission to mainstream Ayurveda through scientific validation and contemporary formulations, RAPL has evolved from humble beginnings into a household name in holistic wellness. With a diverse portfolio of over 400 Ayurvedic and nutraceutical products, RAPL has touched millions of lives, both in India and globally. * Its comprehensive product line offers effective solutions for: * Immunity and immune enhancement * Metabolic and lifestyle disorders * Gastrointestinal health * Women's wellness This strategic focus has firmly established RAPL as a leader in preventive and holistic healthcare. Dynamic Leadership and Innovation Under the leadership of Mr. Salim Diwan, Managing Director of RAPL, the company has achieved numerous milestones, including the establishment of a state-of-the-art manufacturing unit in Rajasthan. Speaking on this milestone Mr. Diwan said: "This isn't just a financial achievement--it's a milestone of trust. Our journey has been driven by the faith people have placed in us. 'Rog Mukt Bharat, Nasha Mukt Bharat' is not merely a slogan; it defines our core purpose. We aim to integrate the timeless principles of Ayurveda with the precision of modern science to offer natural, affordable, and reliable healthcare." A Bollywood actor turned entrepreneur, Mr. Diwan is a passionate advocate for Ayurveda as a tool for public health. His vision has led RAPL to spearhead initiatives such as: * Rural health outreach * Ayurveda education campaigns * Free mobile health units * Digital healthcare platforms These efforts have significantly increased public access to natural healthcare solutions. Global Expansion and Cutting-Edge R & D RAPL continues to invest heavily in research and development, quality control, and innovative product development. All formulations adhere to stringent international quality and safety standards, ensuring efficacy, consistency, and global compliance. With a growing international footprint, RAPL now operates in over 22 countries, including major markets across Europe, the Middle East, and Southeast Asia. The company is at the forefront of transforming Ayurveda from an alternative therapy to an evidence-based, globally accepted healthcare system. Strategic Vision for the Future Looking ahead, RAPL's growth is anchored in a purposeful vision to address the evolving healthcare needs of diverse populations. Key initiatives include: * Strongly countering addiction through Ayurveda * Enhancing women's health and mental well-being * Developing advanced sports nutrition and fitness supplements * Innovating senior health solutions with targeted formulations * Creating diagnostic and wellness programs based on personalized Ayurvedic principles * Collaborating with global universities and research institutions to further validate and promote Ayurvedic science A Celebration of Heritage, Science, and Well-being Surpassing the ₹2000 crore mark is more than a financial victory--it symbolizes a resurgence of India's cultural and medicinal heritage. In an era where consumers are actively seeking sustainable, preventive, and natural healthcare options, Rajasthan Aushdhalaya Pvt. Ltd. stands at the forefront of an Ayurvedic renaissance. With a firm commitment to "Rog Mukt Bharat, Nasha Mukt Bharat," RAPL is not just creating products--it is cultivating a movement. A movement that repositions Ayurveda as a globally trusted system of wellness, with India leading the way.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store